Table 5.

Difference in the inflammatory molecule levels before and at 1 month after cataract surgery in both groups

	Control group (n = 50)			BCL group (n = 50)
	Baseline	1 month	P valuea	Baseline	1 month	P valuea	P valueb
IL-1β	0.51 ± 0.66	0.85 ± 2.8	0.987	0.53 ± 1.28	0.77 ± 1.28	0.096	0.334
IL-6	0.92 ± 1.69	1.49 ± 1.64	0.005	1.09 ± 1.1	1.17 ± 1.32	0.823	0.047
IL-8	25.01 ± 34.03	40.3 ± 46.87	0.038	26.681.32	34.12 ± 41.99	0.451	0.370
IL-10	0.3 ± 0.15	0.31 ± 0.16	0.767	0.24 ± 0.11	0.29 ± 0.23	0.424	0.803
IL-12	5.38 ± 1.37	5.12 ± 2.27	0.245	5 ± 1.08	5.14 ± 1.66	0.648	0.214
TNF-α	0.47 ± 0.48	0.55 ± 0.45	0.128	0.52 ± 0.48	0.67 ± 0.75	0.457	0.607
ICAM-1	1268.06 ± 748.21	1584.54 ± 820.35	0.022	1397.57 ± 696.74	1624.06 ± 954.6	0.122	0.760

TNF tumor necrosis factor; IL interleukin; ICAM intercellular cell adhesion molecule. Data are presented as means ± standard deviation (SD). ^aWilcoxon signed-rank test between baseline and 1 month postoperatively in each group. ^bMann–Whitney U test between two groups in the change of inflammatory molecule levels from baseline to 1 month post-operation. Significant differences are in bold